Rolf Dörr,Diethelm Tschöpe,Nikolaus Marx
Rolf Dörr
Editorial
Herz. 2025 Aug;50(4):227-228. DOI:10.1007/s00059-025-05320-2 2025
Samira Soltani,Johann Bauersachs
Samira Soltani
The diagnosis of heart failure with reduced ejection fraction (HFrEF) is based on clinical symptoms, such as peripheral edema or dyspnea and a left ventricular ejection fraction (LVEF) of 40% or less. Treatment is based particularly on the ...
[Palliative care and change in treatment goals for heart failure in the outpatient sector : A survey among office-based physicians in Germany on the current state of healthcare provision] [0.03%]
德国门诊心脏衰竭患者姑息性治疗和治疗目标变化的调查:当前医疗现状的医师问卷调查
Moritz Blum,Mark Weber-Krüger,Hashim Abdul-Khaliq et al.
Moritz Blum et al.
Background: Palliative care is a crucial part of the holistic management of advanced heart failure; however, it remains unclear how palliative care is currently provided in the outpatient sector in Germany. ...
Big data and cardiovascular risk-insights into obesity, diabetes, and coronary heart disease [0.03%]
大数据与心血管风险——肥胖、糖尿病和冠心病的新认识
Marcus Dörr
Marcus Dörr
Background: Cardiovascular diseases (CVD) remain a major global health burden. Obesity and type 2 diabetes mellitus (T2DM) are key modifiable risk factors for coronary heart disease (CHD). The emergence of big data has re...
Cardiovascular risk reduction in patients with diabetes mellitus and/or chronic kidney disease-an update [0.03%]
糖尿病和/或慢性肾脏病患者的心血管风险降低——更新版
Katharina Marx-Schütt
Katharina Marx-Schütt
People with diabetes mellitus have a significantly increased risk of developing cardiovascular disease as well as chronic kidney disease. The coexistence of these comorbidities has a significant impact on prognosis. In August 2023, the Euro...
Understanding the pathophysiology of obesity-the relevance of weight loss strategies through behavior modification [0.03%]
理解肥胖的病理生理学-通过行为改变减肥策略的相关性
Matthias Blüher
Matthias Blüher
Obesity is a chronic, progressive, and relapsing disease that can contribute to morbidity, reduced life expectancy, and adverse health outcomes. The prevalence of obesity increased worldwide in the past 60 years, mainly because of changes i...
Timing of RAS blocker administration and long-term cardiovascular outcomes in STEMI patients [0.03%]
STEMI患者肾素血管紧张素系统阻滞剂的使用时机及其对长期心血管结局的影响
Tuğba Çetin,Mehmet Baran Karataş,Semih Eren et al.
Tuğba Çetin et al.
Background: Renin-angiotensin system (RAS) blockers constitute a cornerstone in the management of patients with cardiovascular disease. However, the relationship between the administration time of these drugs during the d...
[Bariatric surgery versus GLP-1 and dual GIP/GLP-1 receptor agonists : Effects on weight, risk factors and prognosis] [0.03%]
[减肥手术与GLP-1及双GIP / GLP-1受体激动剂：对体重、危险因素和预后的影响]
Jürgen Ordemann,Ulf Elbelt
Jürgen Ordemann
To overcome the increasing prevalence of obesity and associated secondary diseases, effective treatment strategies are required. While bariatric surgery (BS) is an established method for significant and sustainable weight reduction, drug tr...
Ralf Zahn,Karl Werdan
Ralf Zahn
Editorial
Herz. 2025 Jun;50(3):159. DOI:10.1007/s00059-025-05314-0 2025
Impact of functional mitral regurgitation on outcomes of high-power short-duration pulmonary vein isolation in patients with atrial fibrillation [0.03%]
二尖瓣反流对肺静脉隔离治疗心房颤动患者的影响
A Pinchuk,V Adam,P Biehler et al.
A Pinchuk et al.
Background: Atrial fibrillation (AF) is a common arrhythmia with significant health implications. Mitral regurgitation (MR) frequently coexists with AF and may affect treatment outcomes. ...